1X10^6 TF-1 cells were surface stained with 10.00 ul/test APC Anti-Human CD117 (APC-65154, Clone:104D2) (red) or isotype control antibody (blue). Samples were not fixed.
1X10^6 human peripheral blood granulocytes were surface stained with 5.00 ul APC Anti-Human CD11b (APC-65116, Clone:ICRF44) (red) or isotype control antibody (blue). Samples were not fixed.
100 ul human peripheral blood were surface stained with 5.00 ul APC Anti-Human CD11c (APC-65086, Clone:3.9) and then treated with red blood cell lysis buffer. Cells were not fixed.
1X10^6 human peripheral blood granulocytes were surface stained with 10.00 ul/test APC Anti-Human CD13 (APC-65186, Clone:WM15) (red) or isotype control antibody (blue). Samples were not fixed.
1X10^6 human peripheral blood lymphocytes were surface stained with 0.25 ug FITC Anti-Human CD4 (FITC-65143, Clone: RPA-T4) and 0.25 ug APC Anti-Human CD161 (APC-65115, Clone: HP-3G10). Samples were not fixed.
1X10^6 human peripheral blood lymphocytes were surface stained with 0.25 ug FITC Anti-Human CD4 (FITC-65143, Clone: RPA-T4) and 0.25 ug APC-mouse IgG1 isotype control. Samples were not fixed.
100 ul human peripheral blood were surface stained with 10.00 ul APC Anti-Human CD163 (APC-65169, Clone: GHI/61) or APC mouse IgG1 isotype control antibody. CD14+ monocytes were gated for analysis. Samples were not fixed.
1X10^6 human peripheral blood lymphocytes were surface stained with 0.125 ug APC-anti-human CD19 (APC-65110, clone HIB19) (red) or 0.125 ug APC-mouse IgG1 isotype control (blue). Samples were not fixed.
